ABC Arbitrage’s Terns Pharmaceuticals TERN Stock Holding History

ABC Arbitrage’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-64,303	Closed	-$3.39M	–	481
2026 Q1	$3.39M	Buy	+64,303	New	+$2.64M	0.45%	52

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ABC Arbitrage's TERN Position: Q2 2026 in Review

ABC Arbitrage sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 64,303 shares — an estimated $3.39M sold.

ABC Arbitrage first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $3.39M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

ABC Arbitrage reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
ABC Arbitrage sold 64,303 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.39M.
ABC Arbitrage first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
ABC Arbitrage's Terns Pharmaceuticals position peaked at $3.39M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.